Cell line · CVCL_1107

CAL-27

Cancer cell line, Homo sapiens. Tongue adenosquamous carcinoma. 113 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. CAL-27. Cell lines, record CVCL_1107. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1107

On this page

Cell line

As Cellosaurus gives it.

Name: CAL-27
Accession: CVCL_1107
RRID: RRID:CVCL_1107
Synonyms: Cal-27, CAL 27, Cal 27, CAL27, Cal27, CAL-SCC-27, Centre Antoine Lacassagne-27
Species: Homo sapiens (Human)
Sex: Male
Age at sampling: 56Y
Category: Cancer cell line
Diseases: Tongue adenosquamous carcinoma (NCIt C173807)
Derived from: Oral cavity, tongue (in situ)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers113

Paper	Journal	Year	How we know	Source
Capsaicin suppresses metastasis in tongue squamous cell carcinoma by reversing epithelial-mesenchymal transition via the AMPK/HIF-1α/Claudin-1 axis	Biol Direct	2026	Its Methods give the RRID and name the line	PubMed
Dual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma.	Int J Oral Sci	2026	Its Methods give the RRID and name the line	PubMed
Aberrant Accumulation of Cyclin D1 Rewires Glutamine Metabolism and Generates a Metabolic Vulnerability in Squamous Cell Carcinoma.	Cancer Res	2026	Its Methods give the RRID and name the line	PubMed
NLRX1 contributes to immunotherapeutic resistance of head and neck squamous cell carcinoma by suppressing type I interferon pathway.	Front Immunol	2026	Its Methods give the RRID and name the line	PubMed
Genome-wide CRISPR screen identifies AMBRA1 as a potential biomarker of response to platinum-based therapies in oral squamous cell carcinomas.	iScience	2026	Its Methods give the RRID and name the line	PubMed
Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor-Resistant Head and Neck Squamous Cell Carcinoma.	Cancer Res Commun	2026	Its Methods give the RRID and name the line	PubMed
Serum metabolomics profiling in head and neck squamous cell carcinoma: a multicentre diagnostic study.	EBioMedicine	2026	Its Methods give the RRID and name the line	PubMed
SLC15A4 promotes oral cancer progression by regulating TLR9 and activating the JAK/STAT signaling pathway.	Head Face Med	2026	Its Methods give the RRID and name the line	PubMed
Maackia amurensis seed lectin inhibits oral squamous cell carcinoma tumorigenesis by suppressing N6-methyladenosine modification-mediated SRY-box transcription factor 2 expression.	J Int Med Res	2026	Its Methods give the RRID and name the line	PubMed
Stiffness-related stress granules promote the metastasis of early-stage oral squamous cell carcinoma via anoikis resistance.	Cell Oncol (Dordr)	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 113

See all 113 papers

Relatives7

Relation	Cell line	Accession	Source
Derived from it	CAL-27 2B1	CVCL_C0RK	Cell lines
Derived from it	CAL-27 2B3	CVCL_C0RL	Cell lines
Derived from it	CAL-27 TPFR	CVCL_GY99	Cell lines
Derived from it	EDITGENE CAL-27-CopGFP	CVCL_F6CB	Cell lines
Derived from it	EDITGENE CAL-27-FLUC	CVCL_F5UU	Cell lines
Derived from it	ER-Cal-27	CVCL_EI26	Cell lines
Derived from it	HyCyte CAL-27 stable cell line for hSEMA3G overexpression	CVCL_F4VS	Cell lines

Cell banks7

Cell bank	Catalog number	Source
ATCC	CRL-2095	ATCC
BCRJ	0326	BCRJ
CCTCC	GDC0248	Cellosaurus
CLS	305029	CLS
DSMZ	ACC-446	DSMZ
EDITGENE	EDC00292	EDITGENE
Hysigen	TCH-C148	Hysigen

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1107

GET https://conductscience.org/api/cell-lines/v1/CVCL_1107/papers?page=2

API reference For AI assistants